Biotech & Life Sciences
-
Function Health Connects Your Lab Results to AI — Here’s Why It Matters
Your blood test results just got a lot more useful — if you know how to use them Most people who get lab work done receive a PDF, glance at the numbers, and have no idea what half of them mean. Function Health is trying to change that. On March 20, 2026, the Austin-based health
-
GI Innovation and J&J Team Up to Tackle Advanced Prostate Cancer
A small Korean biotech just secured a deal with Johnson & Johnson to tackle one of prostate cancer’s hardest challenges When a company the size of Johnson & Johnson agrees to supply its drug to a clinical trial run by a smaller biotech, it is not a routine transaction. It is a vote of confidence.
-
How OPTEL Is Reshaping Pharmaceutical Manufacturing
Pharma factories are leaving capacity on the table — and this AI partnership wants to fix that Two Canadian companies just announced a partnership that could change how pharmaceutical manufacturers plan their production. On March 17, 2026, OPTEL and Kaster Technologies revealed a commercial agreement to bring AI-powered production planning to drug manufacturers worldwide. The
-
Why PureHealth Research Focuses on the Liver-Lymph Axis
PureHealth Research Targets the Liver-Lymphatic Connection to Optimize Systemic Detoxification On March 14, 2026, Virginia-based PureHealth Research announced a strategic expansion of its wellness portfolio, focusing on the biological synergy between the liver and the lymphatic system. Moving away from traditional isolated-organ health models, the company is pioneering a systemic approach that addresses how metabolic
-
Small Molecules, Big Data: The AI-Powered Future of Oral Obesity Therapies
PRISM BioLab and Receptor.AI Partner to Navigate the Undruggable PPI Landscape On March 12, 2026, Tokyo-based PRISM BioLab and U.S.-based TechBio firm Receptor.AI announced a strategic collaboration to build an integrated, AI-navigated drug discovery platform. This partnership aims to solve one of the most persistent challenges in pharmacology: the discovery of orally available small molecules
-
16 Billion in Growth? Inside the Rapid Rise of Wire-Free Coronary Physiology
Large-Scale Medicare Study Validates CathWorks FFRangio Outcomes Through Two Years At the Cardiovascular Research Technologies (CRT) 2026 conference in Washington, D.C., researchers presented the first-ever United States Medicare data comparing angiography-derived physiology (ADP) to traditional invasive methods. The study, led by Dr. Christopher Chieh Yang Koo and investigators from Harvard Medical School, analyzed over 4,000
-
SkinCure Oncology Sues Federal Government: The Fight for “Scalpel-Free” Cancer Care
SkinCure Oncology, the provider of a popular nonsurgical skin cancer treatment known as Image-Guided SRT, announced on March 6, 2026, that it has filed a lawsuit in federal court. The company is seeking an emergency injunction to stop new Medicare policies that would significantly limit patient access to this technology. The lawsuit specifically names the
-
Can You Drink Your Way to Better Skin? Vital Proteins Debuts New Collagen Water
Transforming Daily Hydration with Science-Backed Bioactive Peptides Vital Proteins, the industry leader in collagen supplementation, officially debuted its latest innovation on March 4, 2026: Vital Proteins Collagen Sparkling Water. This launch represents a strategic pivot into the high-growth ready-to-drink (RTD) functional beverage space; it offers consumers a “beauty-from-within” solution in a convenient, carbonated format. The
-
Going Private: Consortium to Acquire Select Medical in $3.9 Billion Cash Deal
The healthcare sector just saw a massive consolidation move from the inside out. On March 2, 2026, Select Medical Holdings Corporation (NYSE: SEM) announced it’s being taken private in a $3.9 billion deal. The architect of the move? A consortium led by the company’s own Executive Chairman and Co-Founder, Robert A. Ortenzio, Senior EVP Martin
-
PureHealth Research Debuts “Natural GLP-1 Support” for Needle-Free Weight Care
PureHealth Research has officially entered the metabolic health race with its Natural GLP-1 Support collection. Headlined by the 9-ingredient formula GLP ON, the line aims to provide a needle-free, non-prescription alternative to the high-cost injectable GLP-1 agonists that have dominated the market recently. I’m noticing a strategic shift here. While many “nature’s Ozempic” products rely
